Title of Collaborative Activity: |
Gastrointestinal Drugs Advisory Committee (GIDAC) of the Division of Gastroenterology and Inborn Errors Products of the Center for Drug Evaluation and Research (CDER) of the FDA |
Description of Collaborative Activity: |
Gastrointestinal Drugs Advisory Committee (GIDAC) provides advice and recommendations to the FDA on the need for and design of clinical development programs necessary to support approval of parenteral lipid emulsion products as nutrition support. |
Type of Collaborative Activity: |
Advisory Group
|
Year the Collaborative Activity Originated: |
2012 |
NIH Participating Institutes/Centers/Office of the Director: |
CC |
HHS Agency Collaborators on this Activity: |
FDA |
